MXPA04011944A - Secuencias de control del gen corin humano. - Google Patents

Secuencias de control del gen corin humano.

Info

Publication number
MXPA04011944A
MXPA04011944A MXPA04011944A MXPA04011944A MXPA04011944A MX PA04011944 A MXPA04011944 A MX PA04011944A MX PA04011944 A MXPA04011944 A MX PA04011944A MX PA04011944 A MXPA04011944 A MX PA04011944A MX PA04011944 A MXPA04011944 A MX PA04011944A
Authority
MX
Mexico
Prior art keywords
corin
polynucleotide
control region
expression
gene
Prior art date
Application number
MXPA04011944A
Other languages
English (en)
Spanish (es)
Inventor
Wu Qingyu
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MXPA04011944A publication Critical patent/MXPA04011944A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MXPA04011944A 2002-05-31 2003-05-28 Secuencias de control del gen corin humano. MXPA04011944A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38410802P 2002-05-31 2002-05-31
PCT/US2003/016741 WO2003102135A2 (en) 2002-05-31 2003-05-28 Control sequences of the human corin gene

Publications (1)

Publication Number Publication Date
MXPA04011944A true MXPA04011944A (es) 2005-03-31

Family

ID=29711979

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04011944A MXPA04011944A (es) 2002-05-31 2003-05-28 Secuencias de control del gen corin humano.

Country Status (18)

Country Link
US (1) US20030223976A1 (cg-RX-API-DMAC7.html)
EP (1) EP1546172A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005531302A (cg-RX-API-DMAC7.html)
KR (1) KR20050009724A (cg-RX-API-DMAC7.html)
CN (1) CN1671729A (cg-RX-API-DMAC7.html)
AU (1) AU2003245342A1 (cg-RX-API-DMAC7.html)
BR (1) BR0311603A (cg-RX-API-DMAC7.html)
CA (1) CA2487024A1 (cg-RX-API-DMAC7.html)
CR (1) CR7622A (cg-RX-API-DMAC7.html)
EC (1) ECSP045518A (cg-RX-API-DMAC7.html)
IL (1) IL165244A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04011944A (cg-RX-API-DMAC7.html)
NO (1) NO20045722L (cg-RX-API-DMAC7.html)
PL (1) PL374125A1 (cg-RX-API-DMAC7.html)
RS (1) RS104404A (cg-RX-API-DMAC7.html)
RU (1) RU2004139055A (cg-RX-API-DMAC7.html)
WO (1) WO2003102135A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200410400B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050026255A1 (en) * 2002-06-25 2005-02-03 Morser John Michael Corin, a serine protease
WO2005084223A2 (en) * 2004-02-27 2005-09-15 The General Hospital Corporation Methods and compositions for hair growth
CN101321727B (zh) 2005-12-01 2013-03-27 西巴控股有限公司 肟酯光敏引发剂
US20110306069A1 (en) 2009-02-19 2011-12-15 Qingyu Wu Corin As A Marker For Heart Failure
CN105734070A (zh) * 2016-04-11 2016-07-06 苏州大学 Corin基因变异体及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5917123A (en) * 1997-03-14 1999-06-29 University Of Pittsburgh Transgenic mice containing a nucleic acid encoding tumor necrosis factor-α under the control of a cardiac specific regulatory region
ES2307338T3 (es) * 1998-06-05 2008-11-16 Bayer Schering Pharma Aktiengesellschaft Corina, una serina proteasa.
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
AU2001233262A1 (en) * 2000-02-03 2001-08-14 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2001245671A (ja) * 2000-03-07 2001-09-11 Chiba Prefecture ヒト神経芽細胞腫においてクローニングされた新規遺伝子及び新規遺伝子の断片

Also Published As

Publication number Publication date
KR20050009724A (ko) 2005-01-25
IL165244A0 (en) 2005-12-18
BR0311603A (pt) 2005-06-07
AU2003245342A1 (en) 2003-12-19
RU2004139055A (ru) 2005-08-20
NO20045722L (no) 2004-12-30
RS104404A (sr) 2006-12-15
WO2003102135A2 (en) 2003-12-11
EP1546172A4 (en) 2005-11-30
CA2487024A1 (en) 2003-12-11
JP2005531302A (ja) 2005-10-20
WO2003102135A3 (en) 2004-11-04
US20030223976A1 (en) 2003-12-04
ECSP045518A (es) 2005-03-10
CN1671729A (zh) 2005-09-21
ZA200410400B (en) 2006-06-28
PL374125A1 (en) 2005-10-03
EP1546172A2 (en) 2005-06-29
CR7622A (es) 2006-05-29

Similar Documents

Publication Publication Date Title
JP4063319B2 (ja) 組換えウイルスベクター系
US8476418B2 (en) Modified AAV capsid polypeptides
JP4117023B2 (ja) 組換えウイルスベクター系
US6544786B1 (en) Method and vector for producing and transferring trans-spliced peptides
SK132797A3 (en) Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
JP2022513376A (ja) レトロウイルスインテグラーゼ-Cas9融合タンパク質を使用した指向性非相同DNA挿入によるゲノム編集
AU2019317754B2 (en) Mini-GDE for the treatment of glycogen storage disease III
CN114929735A (zh) 因子viii构建体
KR100501881B1 (ko) 피53단백질변이체및이의치료적용도
CN113613668A (zh) 小型化肌营养不良蛋白及其用途
CN112639108A (zh) 治疗非综合征性感觉神经性听力损失的方法
CN116685329A (zh) 核酸构建体及其用于治疗脊髓性肌肉萎缩症的用途
CN111902164A (zh) 用于恢复pah基因功能的腺相关病毒组合物及其使用方法
JPH11503011A (ja) 条件発現系
Meroni et al. Motifs resembling hepatocyte nuclear factor 1 and activator protein 3 mediate the tissue specificity of the human plasminogen gene
US20030223976A1 (en) Control sequences of the human corin gene
JPH11514881A (ja) Gaxタンパク質の癌治療への応用
WO2002006495A2 (en) Mutant muscle-specific enhancers
US20240181084A1 (en) Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas Fusion Protein and Methods of Treatment
US6294379B1 (en) Efficient AAV vectors
WO2002046220A9 (en) Sequences upstream of the carp gene, vectors containing them and uses thereof
WO2026080685A1 (en) Guide rnas, vectors, and virions for targeting mutations in the pln gene
WO2025129095A1 (en) Compositions and methods for allele-specific myh7 gene editing
JP2000508904A (ja) チロシンヒドロキシラーゼの遺伝子に由来の発現系
EP4695396A1 (en) Guide rnas, vectors, and virions for targeting mutations in the pln gene

Legal Events

Date Code Title Description
FA Abandonment or withdrawal